We studied the incidence of pathogenic bacteria and concurrent infections with human cytomegalovirus (CMV) and herpes simplex virus (HSV) type 1 and 2 in biopsy samples from the placenta and decidua of women with healthy pregnancies. By polymerase chain reaction analysis, we found that 38% of placental samples were positive for selected bacteria and viruses. CMV, HSV-1, and HSV-2 were detected in isolation or with bacteria in first-and second-trimester samples. Certain bacteria were detected more often during the second trimester than during the first-Ureaplasma urealyticum, Mycoplasma hominis, and Gardnerella/Bifidobacterium species. In paired samples from first-trimester tissues, the detection rate for viruses, compared with most bacteria, was higher in the decidua than in the adjacent placenta. In contrast, bacteria were more frequently detected in placenta. Analyses of immunoglobulin G isolated from the placenta support the hypothesis that immune responses suppress CMV reactivation in the presence of pathogenic bacteria at the maternal-fetal interface.
mission can occur by exposure to infected urine, usually through contact with young children [10] . Sexual transmission is recognized as the most common route of CMV infection in adulthood [11, 12] , because cervical secretions and semen act as important virus reservoirs [13] [14] [15] [16] .
The placenta is pivotal in CMV transmission to the fetus, as has been suggested by the unusual anatomy of the maternal-fetal interface (figure 1) [17, 18] . Cytotrophoblasts differentiate into the specialized trophoblast populations of floating and anchoring chorionic villi, which have different properties and functions. Cytotrophoblasts in floating villi fuse into multinucleated syncytiotrophoblasts that cover the villus surface (figure 1, zone 1). These cells are in direct contact with maternal blood and exchange gas, nutrients, and waste products with the fetal compartment. Cytotrophoblasts in anchoring villi (figure 1, zone 2) remain as single cells that aggregate into columns and invade the uterine wall up to the first third of the myometrium. In these locations, cytotrophoblasts invade the decidua and intercalate among maternal immune cells ("interstitial invasion"). Invasive cytotrophoblasts also breach uterine spiral arterioles ("endovascular invasion"). This process has many similarities to tumor invasion, except that the extent and timing of invasion are carefully regulated (figure 1, zone 3). Once inside the blood vessels, cy- totrophoblasts remodel the uterine vasculature, replacing the endothelial cell lining and some of the smooth-muscle cell wall. The result is a hybrid vasculature that is composed of fetal cytotrophoblasts and maternal smooth-muscle cells and that ultimately supplies vast quantities of blood to the surface of floating placental villi.
During pregnancy, viruses and bacteria may be transmitted to the developing placenta via ascending infections, because retrograde transmission from decidual cells through cell columns to anchoring and floating villi is possible. Alternatively, microorganisms could be transmitted through the hematogenous route as cytotrophoblasts invade the uterine vasculature, a process that releases maternal blood into the intervillous space (figure 1, zone 3) [19] . We investigated the prevalence of selected pathogenic bacteria and viruses-CMV, HSV-1, and HSV-2-in decidua and adjacent portions of the placenta from first-and second-trimester pregnancies. To our knowledge, this is the first study to correlate these microorganisms with gestational age and serological and immunohistochemical analyses of tissue biopsy samples. Ureaplasma urealyticum were obtained from the ATCC, C. Hoover (University of California, San Francisco), and Virolab, respectively. Plasmid material from G. vaginalis, Bifidobacterium infantis, and Bacteroides fragilis was obtained from P. Lepp (Stanford University, Stanford, CA). Uninfected cell lines and water were used as negative controls and were included for every 10 samples. Positive controls were included in each run. Samples were tested by polymerase chain reaction (PCR) for the presence of DNA from CMV, HSV-1, HSV-2, and bacteria.
MATERIALS AND METHODS

Samples
PCR. Primers were selected to amplify DNA from the 16S RNA gene of M. genitalium (forward, ccatgctgagaagtagaatagc; reverse, ttgacatgcgcttccaataa), M. hominis [20] , Gardnerella/ Bifidobacterium species [21] , B. fragilis [22] , Chlamydia species [23] , C. trachomatis [23] , and group B streptococcus [24] ; the cppB gene of Neisseria gonorrhoeae [25] ; the urease gene of U. urealyticum [20] ; the immediate-early (UL123) and glycoprotein B (gB) (UL55) genes of CMV [26, 27] ; and the gD and gG genes of HSV-1 and HSV-2 [28] . Primers were manufactured by Operon. Reactions were performed as described elsewhere [28] . In brief, conditions consisted of a hot start at 94ЊC for 2 min, followed by 40 cycles of 94ЊC for 45 s, 50ЊC-60ЊC for 45 s, 72ЊC for 1 min, and a final incubation at 72ЊC for 2 min. With the exception of a nested PCR system to amplify HSV-1 and HSV-2, all reactions consisted of a single round. Fisher's exact test was used to compare PCR results from first-and secondtrimester pregnancies, and McNemar's test was used to analyze the rate of transmission from the decidua to the placenta. was considered to be significant. P ! .05 PCR products obtained by using primers for gB were used for sequencing and typing as described elsewhere [27, 29, 30] . Primers amplified a 400-bp product from the 5 end of the gB gene to beyond the UL55 proteolytic cleavage site [27] . Sequence analysis was performed using GCG, Wisconsin Package version 10.3 (Accelrys).
Additional testing. In situ hybridization and immunohistochemical analyses ( ) were performed on paired n p 23 samples from first-trimester tissues. Tissue-associated IgG was purified from tissue culture-conditioned medium combined from decidual and placental samples [31] and tested for antibodies to CMV, HSV, HIV, and Chlamydia species. Neutralization assays for CMV were performed as described elsewhere [32] . Tissues in which HSV-2 DNA was detected were tested for HSV-2 IgG by use of the OptiCoat ELISA (Biotecx Laboratories). HIV serological testing was performed by J. A. Levy (University of California, San Francisco), and Chlamydia serological testing was performed by Virolab. Immunohistochemical testing to detect CMV proteins was done as described elsewhere, using a pool of mouse monoclonal antibodies to infected cell protein gB [33] and antibodies to cytokeratin [19] . HSV was detected by use of a pool of antibodies to infected cell proteins (authors' unpublished data). To detect Chlamydia proteins, purified goat IgG anti-C. trachomatis to the L2 strain and fluorescein isothiocyanate-labeled donkey F(ab 1 ) 2 fragment anti-goat IgG were purchased from Chemicon and Jackson ImmunoResearch, respectively. Macrophages and dendritic cells (DCs) were identified by use of mouse antibody to CD68 (Dako), and decidual cells were detected by use of goat antiserum to IGFBP-1 (Diagnostic Systems). Nuclei were counterstained with TO-PRO-3 iodide (Molecular Probes), and laser-scanning confocal images were generated by use of a Bio-Rad MRC 1024 confocal Optiphot II Nikon microscope.
RESULTS
Pathogens detected by PCR. PCR was used to test placental and decidual biopsy samples for Mycoplasma species, Bacteroides species, Gardnerella/Bifidobacterium species, group B streptococcus, Ureaplasma species, Chlamydia species, N. gonorrhoeae, CMV, HSV-1, and HSV-2. Results are shown in tables1 and 2. A large number of samples contained DNA from CMV (69%), and fewer contained DNA from group B streptococcus (19%), Gardnerella/Bifidobacterium species (19%), Chlamydia species (17%), Ureaplasma species (16%), and M. hominis (15%). In contrast, there was 1 sample with Bacteroides species (in decidua only), and there were no samples with N. gonorrhoeae.
Thirty-eight percent of placental samples tested positive for both CMV and bacteria (table 1, row 1); 8% tested positive for CMV and HSV-1 or HSV-2 (table 1, row 2). When HSV had infected the decidua, the results of immunohistological analysis showed that the infection was more focal, and viral DNA was not found in the adjacent placenta. In comparison, when CMV and bacteria were detected, they were present in the majority of biopsy samples from each positive tissue sample. CMV gB genotyping results from 7 positive placentas revealed 3 group-1 infections, 2 group-2 infections, 1 group-3 infection, and 1 mixed infection.
Increased pathogens detected during the second trimester. PCR results for first-and second-trimester placental biopsy samples are shown in table 1. There was a significant increase in the number of pathogens from the first to the second trimester for M. hominis (3%-26%;
), Gardnerella/Bifi-P p .02 dobacterium species (6%-31%;
), and Ureaplasma spe-P p .007 cies (10%-23%;
). There was no significant difference P p .01 for CMV (63%-74%;
), HSV-1 (3%; ), and P p .32 P p 1.0 HSV-2 (6%-13%;
). Levels of Bacteroides species and P p .43 M. genitalium were too low for comparison, and no data on Chlamydia species were available for the second trimester. The number of samples that tested negative by PCR was lower in second-trimester samples (26% vs. 8%;
). P p .05 Transmission of pathogens from the decidua to the placenta. PCR results for 35 decidual and adjacent placental samples from the first trimester are shown in table 2. The decidua more often tested positive for CMV than did the pla- 17%; ), or HSV (20% vs. 9%; P p 1.0 ). Low levels of Mycoplasma and Bacteroides species did P p .32 not allow for a comparison between tissue types. In the placenta, there was no significant difference between CMV with bacteria or in isolation (31% vs. 26%;
). The same P p .31 situation existed with respect to the decidua (49% vs. 26%; ). Our results suggest the selective transmission of CMV P p .56 from the decidua to the placenta.
Correlation of PCR with immunohistopathological and serological results. Maternal IgG to CMV was detected in 96% of 23 first-trimester placenta and/or decidual samples, all of which tested positive by PCR and immunocytochemical analysis (table 3) . The remaining samples, which did not contain antibody, also tested positive by PCR and immunohistochemical analysis. These were likely to be primary infections, given that immunohistochemical analysis revealed CMV-infected cell proteins. In a subset of these samples, CMV early transcripts were detected by in situ hybridization in islands of cells in the placenta, more specifically in the cytoplasm of cytotrophoblasts and fibroblasts [31] . CMV-infected cell proteins were detected in decidual cells and the virion envelope gB in macrophages and DCs by immunohistochemical analysis ( figure 2A-C ). Five samples also tested positive for IgG to Chlamydia species. Of these, 3 tested positive by PCR. None were seropositive for IgG to HIV. Chlamydia species was detected in decidual cells and glandular epithelial cells, with staining patterns revealing submembrane localization ( figure 2G-2I ). This pattern was not observed in tissues, which were negative by PCR (figure 2D-2F and 2J-2L). IgG was purified from 4 of 5 samples that tested positive for HSV by PCR and immunocytochemical analysis. Of these, 2 were positive for anti-HSV-2 IgG. When HSV infected the decidua, the results of immunohistological analysis showed that the infection was more focal and that viral DNA was infrequently found in the adjacent placenta.
As seen in figure 2 , results of immunohistochemical analysis showed staining for Chlamydia and CMV proteins in sections from decidual biopsy samples. Combined PCR and immunohistochemical and serological results can be classified into 3 groups (table 3) . First, many foci of CMV-infected cells detected by immunohistochemical analysis in both decidual and placental samples correlated with many cases of very low CMV neutralizing antibody titers and were likely primary infections (group A). Bacteria were rarely detected in this group; Bacteroides species were found only in the decidua of 1 sample. Second, when occasional CMV-infected cells were detected in decidua (group B), macrophages and DCs with viral proteins were found in the decidua and placenta. Most of the CMV neutralizing antibody titers were low to moderate in this group. Bacteria were present in 5 (71%) of 7 of these cases. Third, when CMV DNA was detected in both decidua and placenta along with pathogenic bacteria, moderate to high levels of CMV neutralizing antibodies were found (70% of tissues; group C). NOTE. Cytomegalovirus (CMV)+++ (decidua), infected cell proteins in glandular epithelium, endothelial, and decidual cells; CMV+++ (placenta), infected cell proteins in cytotrophoblast progenitor cells, cell columns, and villus core fibroblasts, and many glycoprotein B (gB)-containing vesicles in macrophages and syncytiotrophoblasts; CMV++ (decidua), few infected epithelial, endothelial, and decidual cells; CMV++ (placenta), gBcontaining vesicles in macrophages and syncytiotrophoblasts; CMV+ (decidua), gB-containing vesicles in macrophage and dendritic cells only; CMV+ (placenta), gB-containing vesicles in syncytiotrophoblasts and villus core macrophages.
a CMV serological results, showing the percentage CMV neutralization. Low, 0%-39%; moderate, 40%-69%; high, 70%-99% neutralizing titer per 100 mg of total IgG which suggested initial or primary infection, recent, and past infection, respectively [55] [56] [57] . b Data are presented as international units. These cases correlated with few CMV-infected cells and the presence of virion gB in macrophages and DCs. This pattern of high neutralizing titers and pathogenic bacteria and virion protein capture by immune cells suggested the reactivation of CMV infection as a consequence of inflammatory responses. One important observation is that CMV DNA was not always detected in cases where immunohistochemical analysis identified CMV proteins. This discrepancy was seen in placental tissues ( ), rather than in decidual tissues ( ). A low n p 8 n p 1 level of gB was detected in the majority of these cases (6/9); however, 3 of 9 contained infected cell proteins.
DISCUSSION
Certain bacteria are associated with bacterial vaginosis and preterm birth [4, 6, 34, 35] . Similarly, CMV is associated with certain pregnancy complications, including the restriction of intrauterine growth [36] [37] [38] . In the present study, 69% of first-and secondtrimester placental biopsy samples from uncomplicated pregnancies tested positive for CMV DNA. Others have reported CMV in cervical and placental samples in late gestation, with higher detection rates in abnormal pregnancies [1, 39] . Differences in detection rates may be due to the sensitivity of the methods used. The prevalence of primary and reactivating CMV infection in these populations may also account for some of the variation.
The risk of contamination of tissues was also considered, given that they were collected through the vaginal canal. PCR results for CMV, HSV-1 and HSV-2, and Chlamydia species were confirmed by immunohistochemistry. Both assays showed that HSV infection was focal and was generally detected in the decidua only. CMV virion proteins were found in cytotrophoblasts, endothelial cells, and immune cells. Virion nucleocapsids were detected in syncytiotrophoblasts by electron microscopy, which indicates that these tissues were positive and not the result of vaginal contamination. Chlamydia proteins were detected within diverse cell types in the uterine decidua. This suggests, but does not prove, that the same situation exists for the other organisms detected. In agreement with previous findings, we also found that PCR combined with immunohistochemical analyses provided a higher CMV detection rate in the placenta [40] . PCR is considered to be the most sensitive detection system available; however, the assay did not identify several cases in which the staining of CMV proteins was observed by immunohistochemical analysis. The PCR assays that we used are capable of detecting DNA from 1-10 virions. Therefore, the differences in detection rates may be due to the small amount of tissue processed for each assay, combined with the focal nature of the infection.
Results of CMV gB genotyping identified different strains and are similar to genotypes reported by others [27, 29, 30, 41] . Of importance, only 1 mixed infection was found in 7 analyzed (most likely a case of primary CMV in a seronegative woman), which suggests that reinfection did not commonly occur in seropositive women.
We found that paired samples with low levels of neutralizing CMV antibody (group A) were more often positive for viral DNA and CMV-infected cell proteins in various cell types in the decidua and adjacent placenta, compared with samples that had high neutralizing titers (group C). Our data suggest that, when CMV neutralizing antibody titers are low, the risk of viral transmission from the decidua and infection of the adjacent placenta is high. Donors in group A might have had primary infections, because rates of transmission to the fetus, which may occur via the placenta [19] , are higher (30%-40%) than in reactivation of a latent infection (!1%) [11, 42] . Ascending infection of the uterus might occur from the cervix in cases of sexual transmission [43, 44] . CMV could spread in a retrograde manner from infected endometrial glands, vascular endothelium, and decidual cells to invasive cytotrophoblasts in cell columns that anchor the placenta to the uterus (figure 1, sites 1-3) [19] . IgG-virion complexes might undergo transcytosis across placental syncytiotrophoblasts ( figure 1, site 4) . Bacterial infections possibly cause inflammatory responses, whereby latently infected macrophages and DCs in the decidua could reactivate virus [45] . In this situation, progeny virions could be eliminated by neutralizing antibody and innate immune cells, thereby suppressing infection. Our immunohistological results suggest that virion proteins in syncytiotrophoblasts overlap IgG-virion complexes and, in seropositive women with high neutralizing titers, could prevent viral penetration and replication [31] .
Studies on the effect of bacterial infection on CMV reactivation in vivo are limited. Bacterial sepsis causes the reactivation of murine CMV, probably through inflammatory mediators such as lipopolysaccharide, tumor necrosis factor-a, and interleukin-8 [46] . These mediators are known to activate transcription factors that drive immediate-early gene expression and lytic CMV replication [47] . Costimulatory molecules, which are induced by Toll-like receptors (TLRs), attract T cells through the secretion of cytokines [48] , and CMV is known to activate these responses via TLR-2 [49] . Although the use of clinical samples means that not all of the cases studied fall neatly into clear groupings, we found that tissue from donors with moderate to high CMV neutralizing antibody titers often contained bacterial DNA, especially group B streptococcus, followed by Ureaplasma, Gardnerella/Bifidobacterium, and Chlamydia species and M. hominis. In these cases, virus was detected at low levels in immune cells in decidua (macrophages/DCs) and uterine blood vessels (neutrophils) only. Inflammation has been found to aid the dissemination of CMV through the recruitment of virus-infected neutrophils and monocytes to sites of infection [50] . Our data support the hypothesis that, in these cases, inflammation caused by pathogenic bacteria could trigger the reactivation of CMV at the uterine-placental interface in the microenvironment of maternal hyporesponsiveness during gestation. We have also shown that immune cells sequester virus in antibody-positive tissues, which suggests that innate immune responses play a central role in reduced infection.
Cellular immune responses to CMV likely increase with the reactivation of CMV. In adults with healthy immune systems, the frequency of memory T cells specific for CMV was significantly higher than those for other herpesviruses, which suggests that sites of latency and age could be important factors [51] . High levels of antigen-specific cells that recognize CMV peptides may be 14% of CD8 + T cells in immunocompetent donors [52] . A substantial proportion of these are effector cytotoxic T lymphocytes that can lyse peptide-pulsed targets. Cytokine responses in the absence of antigen were significantly higher in CMV-seropositive donors, which suggests recent reactivation [53] . Together, these findings suggest that the immune response to CMV is periodically boosted by a low level of viral replication and that sustained immunological surveillance contributes to the maintenance of host-pathogen homeostasis.
The results of recent studies have highlighted the need to better understand the mechanisms of virus transmission across the placenta and the factors that cause congenital CMV infection in immune mothers [42, 54] . We have described different routes of virus transmission from the uterus to the adjacent placenta in early gestation and suggest that virus load can influence pregnancy outcome [19, 31] . Studies in progress are examining the patterns of cytokine and chemokine expression at the maternalfetal interface in the context of primary and reactivated CMV infection.
